Kristen Fortney

Insider Reports History

Location
Richmond, CA
Signature
/s/ Dov A. Goldstein as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kristen Fortney:

Company Role Class Num Shares Value Price $ Report Date Ownership
BioAge Labs, Inc. Chief Executive Officer, Director Common Stock 976,949 $17,698,701 $18.12 13 Jan 2026 Direct
BioAge Labs, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 330,000 17 Feb 2026 Direct

Insider Reports Filed by Kristen Fortney

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BIOA BioAge Labs, Inc. 17 Feb 2026 1 $0 4 Chief Executive Officer, Director 19 Feb 2026, 16:36
BIOA BioAge Labs, Inc. 13 Jan 2026 1 -$4,223,036 4 Chief Executive Officer, Director 15 Jan 2026, 16:20
BIOA BioAge Labs, Inc. 18 Feb 2025 1 $0 4 Chief Executive Officer, Director 20 Feb 2025, 16:17
BIOA BioAge Labs, Inc. 25 Sep 2024 0 $0 3 Chief Executive Officer, Director 25 Sep 2024, 16:44
BIOA BioAge Labs, Inc. 17 Apr 2024 2 $0 4 Chief Executive Officer, Director 27 Sep 2024, 16:25